Navigation Links
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
Date:4/23/2009

points should be considered when initiating therapy with PEGINTRON in combination with REBETOL: (1) These indications are based on achieving undetectable HCV-RNA after treatment for 24 or 48 weeks and maintaining a Sustained Virologic Response (SVR) 24 weeks after the last dose. (2) Patients with the following characteristics are less likely to benefit from retreatment after failing a course of therapy: previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and genotype 1 infection. (3) No safety and efficacy data are available for treatment of longer than one year.

PEGINTRON is also indicated for use alone for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with interferon alpha and who are at least 18 years of age.

The following points should be considered when initiating therapy with PEGINTRON alone: Combination therapy with REBETOL is preferred over PEGINTRON monotherapy unless there are contraindications to, or significant intolerance of, REBETOL. Combination therapy provides substantially better response rates than monotherapy.

Important Safety Information Regarding U.S. Labeling for PEGINTRON and REBETOL

WARNING: RISK OF SERIOUS DISORDERS AND RIBAVIRIN-ASSOCIATED EFFECTS

Alpha interferons, including PEGINTRON, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Patients with persistently severe or worsening signs or symptoms of these conditions should be withdrawn from therapy. In many, but not all cases, these disorders resolve after stopping PEGINTRON therapy.

Use with Ribavirin: Ribavirin may cause birth defects and death of the unborn child. Extreme care must be taken to avoid pregnancy in fem
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
4. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
5. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
6. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
7. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
8. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
9. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
10. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
11. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... to find the best plan at the right price ... Through the end of the year, thousands of Nebraska ... health coverage. This is when the state,s 268,000 ... will sign up and pay for in 2010. ... this decision, says Independent Retail Pharmacist Steve Osenbaugh, of ...
(Date:12/15/2009)... -- Dynatronics Corporation (Nasdaq: DYNT ... agreement to provide therapy equipment and rehab supplies ... network of physical, occupational and speech therapy clinics. ... Therapy Providers," said Larry K. Beardall, executive vice ... vast network of 1,100 clinics is the largest ...
(Date:12/15/2009)... Reportlinker.com announces that a new market research ... Boehringer Ingelheim GmbH: PharmaVitae Profile ... ,, This analysis examines the historical ... the Rx pharmaceutical sector. The profile encompasses ... assessment of financial performance, with 1-6 year ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc. 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7AlphaRx Presents Positive Preclinical Data on Zysolin 28TM 29 Inhalable Nanoparticles at Controlled Release Society Annual Meeting 52512 1AlphaRx Presents Positive Preclinical Data on Zysolin 28TM 29 Inhalable Nanoparticles at Controlled Release Society Annual Meeting 52512 2AlphaRx Presents Positive Preclinical Data on Zysolin 28TM 29 Inhalable Nanoparticles at Controlled Release Society Annual Meeting 52512 3The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide Related Death and Inj 52509 1The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide Related Death and Inj 52509 2The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide Related Death and Inj 52509 3The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide Related Death and Inj 52509 4The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide Related Death and Inj 52509 5The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide Related Death and Inj 52509 6Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 1Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 2
(Date:12/15/2009)... Alto Networks(TM), the network security company, today announced ... next-generation firewalls for accurate threat prevention on its ... over applications such as peer-to-peer file sharing. ,, ... eight facilities on five campuses. The university was ... academic schools and institutions throughout Japan. It is ...
(Date:12/15/2009)... Proceeds will be donated to the Lupus Foundation of ... ,, WASHINGTON, Dec. 15 Julian Lennon, son ... today released their new digital single, "LUCY," to raise ... until March 15, 2010, 100 percent of the proceeds ... the Lupus Foundation of America (LFA), and the Saint ...
(Date:12/15/2009)... NEW YORK, Dec. 15 Vitech Systems ... Customer Relationship Management (CRM) software, announced today that ... CRM implementation for the Screen Actors Guild-Producers Pension ... provides advanced customer service capabilities to SAG-PH call ... The system was installed using Vitech,s V3 Benefits ...
(Date:12/15/2009)... of leptin associated with lower dementia risk, research finds ... levels of leptin, a hormone that regulates appetite, may ... in 10 or 15 years this may be one ... risk of Alzheimer,s disease," said senior study author Dr. ... University School of Medicine. "Or it may be one ...
(Date:12/15/2009)... than needed for protection, CDC says, , , TUESDAY, Dec. ... H1N1 swine flu vaccine have been recalled by manufacturer ... federal health officials said Tuesday. , According to the ... routine testing of the vaccine for children aged 6 ... had lower than required potency levels. "This means that ...
Breaking Medicine News(10 mins):Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Large Recall of Children's Swine Flu Vaccine 2
... It could be a catch-22 situation for some overweight ... problems//. ,Doctors treating overweight or obese patients often ... off pounds. , ,But researchers led by psychologist ... that some people's ability to exercise may be hampered ...
... death of several seabirds on the Gulf of Carpentaria in ... harboring the bird flu virus//. ,However, the Australian ... for panic and that they were sending out a team ... a second team with a military operative has also started ...
... overdose of insulin led to the death of 62-year-old Moira ... wrong dose was administered by a nurse who failed to ... doctor. The overdose of insulin resulted in bronchial pneumonia after ... of one nurse was misread by another, leading to the ...
... at the University of California who has been conducting ... that more than// 32,000 neurons (brain cells) die in ... In addition, nearly 14 billion synapses (connections between nerve ... lost in just a single minute following the attack. ...
... pharmaceutical giant Roche confirmed that it is in talks with ... of Tamiflu, the bird-flu drug//. , ,The partnership ... are stockpiling the drug in preparation for a possible bird ... that it was in talks with Teva Pharmaceuticals and Mylan ...
... cells in the brain die every minute, and the brain ... study//. ,The average stroke involves 54 milliliters of ... hours to evolve, the study author Dr Jeffrey L. Saver ... Association's journal Stroke, January 2005 issue. , ...
Other Medicine News:Health News:Stroke Destroys Nearly 32, 000 Neurons In Just A Second! 2Health News:Roche confirms Tamiflu production talks in US 2Health News:Brain cells by millions die during a stroke 2
... Ulti-Mist™ HME product line has the right ... to adults and from intubated patients to ... humidification for both anesthesia and critical care ... provide maximum protection for patients and staff ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Medicine Products: